Skip to main content

CTOS 2025 Main banner

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Ana Sebio García, MD, PhD

Medical Oncologist
Hospital de la Santa Creu i Sant Pau, IR Sant Pau
Barcelona, Catalonia, Spain

Presentation(s):

Paper 12 - INTEGRATED EFFICACY AND SAFETY ANALYSIS OF LETETRESGENE AUTOLEUCEL, A T-CELL RECEPTOR T-CELL THERAPY, ACROSS CLINICAL TRIALS OF PATIENTS WITH SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA

Thursday, November 13, 2025
1:30 PM - 3:00 PM EST
Disclosure information not submitted.
Paper 14 - IMMUNOSARC2 (COHORT 7A): A SPANISH SARCOMA GROUP (GEIS) PHASE IB TRIAL OF EPIRUBICIN AND IFOSFAMIDE PLUS NIVOLUMAB IN FIRST LINE OF ADVANCED UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)

Thursday, November 13, 2025
1:30 PM - 3:00 PM EST
Disclosure information not submitted.
Paper 31 - THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN CHONDROSARCOMA: RESULTS FROM THE RANDOMIZED, REGISTRATIONAL, PHASE 2 CHONDRAGON STUDY

Friday, November 14, 2025
8:30 AM - 10:00 AM EST
Disclosure information not submitted.
Paper 55 - INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF SPINDLE CELL/ SCLEROSING RHABDOMYOSARCOMA, A PUSH PLATFORM STUDY

Friday, November 14, 2025
5:00 PM - 6:00 PM EST
Disclosure information not submitted.